http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_516e2e92958895fd6a2a3fb492743385
Outgoing Links
Predicate | Object |
---|---|
family-name | Shaw |
name | Alice T Shaw Alice T. Shaw |
given-name | Alice T. Alice T |
organization-name | Massachusetts General Hospital, Boston, Massachusetts, USA Authors' Affiliations: 1Synta Pharmaceuticals Corp., Lexington; 2Massachusetts General Hospital Cancer Center, Boston, Massachusetts; Departments of 3Pathology and 4Oncology, St. Jude Children's Research Hospital, Memphis; 5Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine; 6Insight Genetics, Nashville; 7Morris Laboratories/HealthChart LLC, Memphis, Tennessee; and 8Division of Medical Oncology, University of Colorado Cancer Center, Aurora, Colorado All authors: Massachusetts General Hospital, Boston, MA. Anna F. Farago and Alice T. Shaw, Massachusetts General Hospital Cancer Center; Martin S. Taylor, Nora K. Horick, Jochen K. Lennerz, Long P. Le, A. John Iafrate, and Mari Mino-Kenudson, Massachusetts General Hospital, Boston, MA; Robert C. Doebele and Dara L. Aisner, University of Colorado, Aurora, CO; Viola W. Zhu and Sai-Hong I. Ou, University of California, Irvine, School of Medicine, Orange; Shivaani Kummar, Stanford University, Palo Alto, CA; Alexander I. Spira, Virginia Cancer Specialists, Fairfax,... Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, United States Justin F. Gainor, Diane Tseng, Satoshi Yoda, Ibiayi Dagogo-Jack, Jessica J. Lin, Harper G. Hubbeling, Leila Dardaei, Anna F. Farago, Katherine R. Schultz, Lorin A. Ferris, Zofia Piotrowska, Mari Mino-Kenudson, A. John Iafrate, Aaron N. Hata, Beow Y. Yeap, and Alice T. Shaw, Massachusetts General Hospital, Boston, MA; Luc Friboulet, Institut National de la Santé et de la Recherche Médicale U981, Villejuif, France; and James Hardwick and Donghui Huang, Pfizer Worldwide Research and Development, La Jolla, CA. From the Massachusetts General Hospital Cancer Center (A.T.S.) and Pfizer (G.P.) - both in Boston; Sarah Cannon Research Institute-Tennessee Oncology, Nashville (T.M.B.); European Institute of Oncology, IRCCS (F.M.), and Pfizer (A.P., A.M.C.) - both in Milan; Vall d'Hebron University Hospital and Institute of Oncology, International Oncology Bureau-Quirón, Barcelona (E.F.); National Cancer Center Hospital, Tokyo (Y.G.); Princess Margaret Cancer Centre, Toronto (G.L.); Toulouse University Hospital, Toulouse, France (J.M.); Seoul National University College of Medicine and Seoul National University Hospital, Seoul, South Korea (D.-W.K.); State Key Laboratory of Translational Oncology, Chinese University of Hong Kong, Hong Kong (T.M.); Pfizer, La Jolla, CA (H.T.); and Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.J.S.). 3Novartis Institute of BioMedical Research, Cambridge, Massachusetts.; 4Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. From the Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA; Hematology/Oncology Fellowship Program, Moffitt Cancer Center, Tampa, FL; University of South Florida, Tampa, FL; Department of Thoracic Oncology, Moffitt Cancer Center, Tampa, FL. Massachusetts General Hospital Cancer Center, Boston, MA.; Department of Medicine, Massachusetts General Hospital, Boston, MA. a Massachusetts General Hospital Cancer Center; b Harvard Medical School, Boston, Massachusetts; c MIT, Koch Institute for Integrative Cancer Research, Cambridge, Massachusetts Department of Oncology and Medical Radiotherapy, Massachusetts General Hospital, Boston, MA, USA. 1Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; 2Harvard Medical School, Boston, Massachusetts. Authors' Affiliations: 1Massachusetts General Hospital Cancer Center; and 2Department of Medicine, Harvard Medical School, Boston, Massachusetts; Authors' Affiliations: 1Massachusetts General Hospital Cancer Center; and 2Department of Medicine, Harvard Medical School, Boston, Massachusetts Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA.; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. 1Massachusetts General Hospital Cancer Center and Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts. Massachusetts General Hospital Cancer Center, Boston, MA 02129;; Department of Medicine, Harvard Medical School, Boston, MA 02115;; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139; 1Massachusetts General Hospital Cancer Center and Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.; 2Harvard Medical School, Boston, Massachusetts. D. Ross Camidge, University of Colorado Cancer Center, Aurora, CO; Dong-Wan Kim, Seoul National University Hospital; Myung-Ju Ahn, Samsung Medical Center; Dae Ho Lee, Asan Medical Center, Seoul, South Korea; Marcello Tiseo, University Hospital of Parma, Parma, Italy; Corey J. Langer, University of Pennsylvania, Philadelphia, PA; Alice T. Shaw, Massachusetts General Hospital, Boston; William Reichmann, Jeff Haney, Tim Clackson, and David Kerstein, ARIAD Pharmaceuticals, Cambridge, MA; Rudolf M. Huber,... Authors' Affiliations: 1Massachusetts General Hospital Cancer Center; 2Department of Medicine, Harvard Medical School, Boston, Massachusetts; 3Genomics Institute of the Novartis Research Foundation, San Diego, California; 4Cancer Chemotherapy Center and 5Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan; Authors' Affiliations: 1Massachusetts General Hospital Cancer Center; 2Department of Medicine, Harvard Medical School, Boston, Massachusetts; 3Genomics Institute of the Novartis Research Foundation, San Diego, California; 4Cancer Chemotherapy Center and 5Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan Department of Medicine, Harvard Medical School, Boston, Massachusetts. Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA Departments of aMedicine, 6Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA 7Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. 1Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; 5Harvard Medical School, Boston, Massachusetts.; 8Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts. Author affiliations appear at the end of this article. Massachusetts General Hospital Cancer Center, Boston, MA, USA 3Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; 4Department of Medicine, Harvard Medical School, Boston, Massachusetts. Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA.; Harvard Medical School, Boston, MA 02115, USA. 6Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts. Massachusetts General Hospital, Boston, MA, USA. Electronic address: ASHAW1@mgh.harvard.edu. Koch Institute for Integrative Cancer Research,; Department of Biology, and; Massachusetts General Hospital Cancer Center Home Cancer Center and Harvard Medical School, Boston, MA 02114; and 12Massachusetts General Hospital Cancer Center and Department of Medicine, Massachusetts General Hospital Harvard Medical School, Boston, Massachusetts. Alice T. Shaw and Jeffrey A. Engelman, Massachusetts General Hospital Cancer Center, Boston; Alice T. Shaw, Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology, Cambridge, MA. Massachusetts General Hospital Cancer Center, Department of Medicine and Harvard Medical School, Boston, MA 02114, USA. Massachusetts General Hospital Cancer Center Massachusetts General Hospital Boston Massachusetts; Department of Medicine Massachusetts General Hospital Boston Massachusetts 1Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; 3Dana-Farber Cancer Center, Boston, Massachusetts. Authors' Affiliations: Departments of 1Medicine and 2Pathology, Massachusetts General Hospital, Boston, Massachusetts; Departments of 3Medicine and 4Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York; and 5Department of Medicine, University of California, Irvine, Orange, California Shirish M. Gadgeel, Karmanos Cancer Institute, Wayne State University, Detroit, MI; Alice T. Shaw, Massachusetts General Hospital; Leena Gandhi, Dana-Farber Cancer Institute, Boston, MA; Ramaswamy Govindan, Washington University School of Medicine, St Louis, MO; Mark A. Socinski, University of Pittsburgh, Pittsburgh, PA; D. Ross Camidge, University of Colorado Cancer Center, Denver, CO; Alberto Chiappori, Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Sai-Hong Ignatius... 1Massachusetts General Hospital Cancer Center, Charlestown, Massachusetts.; 2Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. Harvard Medical School, Boston, Massachusetts. From the Massachusetts General Hospital Cancer Center; Departments of Pathology and of Radiology, Massachusetts General Hospital; Hematology/Oncology Division, Beth Israel Deaconess Medical Center; and Department of Pathology, Brigham and Women's Hospital, Boston, MA; and Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia. Massachusetts General Hospital Boston Massachusetts Massachusetts General Hospital Cancer Center, Boston, MA Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA Authors' Affiliations: 1Stanford Cancer Center, Stanford, California; 2Harvard Medical School, Massachusetts General Hospital Cancer Center, Center for Thoracic Cancers, Boston, Massachusetts 1Massachusetts General Hospital, Boston, Massachusetts.; 4Harvard Medical School, Boston, Massachusetts. Massachusetts General Hospital, Boston, MA Ibiayi Dagogo-Jack and Alice T. Shaw, Massachusetts General Hospital, Boston, MA 1Center for Cancer Research and Department of Biology, Massachusetts Institute of Technology;; 3Massachusetts General Hospital Cancer Center and Harvard Medical School;; 5Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts Massachusetts General Hospital Cancer Center Authors' Affiliations: 1Department of Medicine, Vanderbilt University School of Medicine and Vanderbilt Ingram Cancer Center, Nashville, Tennessee; and 2Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 1Massachusetts General Hospital Cancer Center, Charlestown, Massachusetts.; 2Department of Medicine, Harvard Medical School, Boston, Massachusetts. 9Massachusetts General Hospital, Boston, Massachsuetts. Lucio Crinò, University Medical School of Perugia, Azienda Ospedale Perugia, Perugia; Filippo De Marinis, European Institute of Oncology, Milan; Giorgio Scagliotti, University of Torino, Torino, Italy; Myung-Ju Ahn, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, South Korea; Harry J.M. Groen, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Heather Wakelee, Stanford University Medical Center, Stanford, CA; Toyoaki Hida, Aichi Cancer... Ibiayi Dagogo-Jack, Lorin A. Ferris, Jessica J. Lin, Katherine R. Schultz, Jennifer Ackil, Sara Stevens, Leila Dardaei, Satoshi Yoda, Harper Hubbeling, Subba R. Digumarthy, Aaron N. Hata, Lecia V. Sequist, Inga T. Lennes, Anthony John Iafrate, Rebecca S. Heist, Christopher G. Azzoli, Anna F. Farago, Jochen K. Lennerz, Cyril H. Benes, Alice T. Shaw, and Justin F. Gainor, Massachusetts General Hospital, Boston; and A. Rose Brannon, Catarina D. Campbell, Markus Riester, Jeffrey A. Engelman, and Rebecca J.... Harvard Medical School and Massachusetts General Hospital Cancer Center, Boston, Massachusetts. Institute of Cancer Sciences, Massachusetts General Hospital, Boston, MA, USA. From the Massachusetts General Hospital Cancer Center, Boston, MA. Authors' Affiliation: Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts Authors' Affiliations: 1Thoracic Oncology Center, Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts; and 3Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia; Authors' Affiliations: 1Thoracic Oncology Center, Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts; and 3Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia Massachusetts General Hospital Cancer Center, Boston2Harvard Medical School, Boston, Massachusetts Daniel B. Costa, Beth Israel Deaconess Medical Center, Harvard Medical School; Alice T. Shaw, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Sai-Hong I. Ou, Chao Family Comprehensive Cancer Center, University of California Irvine School of Medicine, Irvine; S. Martin Shreeve, Paulina Selaru, and Keith D. Wilner, Pfizer Oncology, La Jolla, CA; Benjamin J. Solomon, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Gregory J. Riely, Memorial Sloan-Kettering Cancer Center;... 1Massachusetts General Hospital Cancer Center, Boston, Massachusetts. 3Massachusetts General Hospital, Boston, Massachusetts. 1Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts. Massachusetts General Hospital Cancer Center, Boston, MA 02129, USA.; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. Jessica J. Lin, Satoshi Yoda, Beow Y. Yeap, Ibiayi Dagogo-Jack, Nicholas A. Jessop, Ginger Y. Jiang, Long P. Le, Aaron N. Hata, Justin F. Gainor, Anthony J. Iafrate, and Alice T. Shaw, Massachusetts General Hospital, Boston; Alexa B. Schrock, Kyle Gowen, Philip J. Stephens, Jeffrey S. Ross, Siraj M. Ali, and Vincent A. Miller, Foundation Medicine, Cambridge, MA; Viola W. Zhu and Sai-Hong Ignatius Ou, Chao Family Comprehensive Cancer Center, University of California Irvine School of Medicine, Orange, CA;... 8Massachusetts General Hospital, Boston, Massachusetts. |
Incoming Links
Total number of triples: 260.